| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/21/2008 | CA2677937A1 Use of sucrose to suppress mannitol-induced protein aggregation |
| 08/21/2008 | CA2677932A1 Glucagon/glp-1 receptor co-agonists |
| 08/21/2008 | CA2677818A1 The secreted protein ccdc80 regulates adipocyte differentiation |
| 08/21/2008 | CA2677749A1 Method of treating or preventing tissue deterioration, injury or damage due to disease of mucosa |
| 08/21/2008 | CA2677703A1 Methods of correcting imbalance between bone resorption and bone formation and kits and compositions therefor |
| 08/21/2008 | CA2677605A1 Activin-actriia antagonists and uses for promoting bone growth in cancer patients |
| 08/21/2008 | CA2677452A1 Compositions for increasing body weight, use and methods |
| 08/21/2008 | CA2677397A1 Treatment of inflammatory diseases using placental stem cells |
| 08/21/2008 | CA2676297A1 Inhibitors of hepatitis c ns3 protease |
| 08/21/2008 | CA2675793A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 08/21/2008 | CA2675602A1 Protein formulations containing sorbitol |
| 08/21/2008 | CA2674773A1 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| 08/21/2008 | CA2673573A1 Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury |
| 08/21/2008 | CA2662684A1 High affinity ephb receptor binding compounds and methods of use thereof |
| 08/21/2008 | CA2621452A1 Stent and method for reducing tissue damage after ischemic injury with thymosin b4 |
| 08/20/2008 | EP1959013A1 Human circulating virus inhibitory peptide (VRIP) and its use |
| 08/20/2008 | EP1958966A2 Methods for modulating T cell responses by manipulating a common cytokine receptor gamma chain |
| 08/20/2008 | EP1958965A2 Agonist antibodies to a musk receptor, and their therapeutic uses |
| 08/20/2008 | EP1958963A1 Oxygen-carrying blood substitute preparations |
| 08/20/2008 | EP1958960A2 A process for the preparation of a non-toxic anthrax vaccine |
| 08/20/2008 | EP1958958A1 Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic methods and vaccines |
| 08/20/2008 | EP1958957A1 Polypeptide comprising a knottin protein moiety |
| 08/20/2008 | EP1958956A2 Peptidomimetic protease inhibitors |
| 08/20/2008 | EP1958648A1 Therapeutic method for blood coagulation disorder |
| 08/20/2008 | EP1958643A2 Stable formulations containing enhancing proportions of gamma- and alpha-interferons |
| 08/20/2008 | EP1958642A1 Regulation of cell growth by MUC1 |
| 08/20/2008 | EP1958623A1 Poly(Lactide-Co-Glycolide)-based sustained release microcapsules comprising a polypeptide and a sugar |
| 08/20/2008 | EP1958503A2 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 08/20/2008 | EP1957657A2 A biomarker of improved intestinal function |
| 08/20/2008 | EP1957649A1 Process for the production, in prokaryotes, of active, stable transposases of mariner mobile genetic elements |
| 08/20/2008 | EP1957524A1 Targeted fusion proteins for cancer therapy |
| 08/20/2008 | EP1957517A2 Use of peptides that bind to tpo receptor |
| 08/20/2008 | EP1957113A2 Polymer particles for delivery of macromolecules and methods of use |
| 08/20/2008 | EP1957098A1 Management of non septic patients suffering from partial thickness burns during the first 48 postburn hours by administration of activated protein c |
| 08/20/2008 | EP1957097A1 Interleukin-11 compositions and methods of use |
| 08/20/2008 | EP1957095A2 Modified annexin proteins and methods for their use in organ transplantation |
| 08/20/2008 | EP1957094A2 Calcium binding peptides |
| 08/20/2008 | EP1957093A2 Neuroprotective and neurorestorative methods and compositions |
| 08/20/2008 | EP1957082A1 Use of high-dose oxazaphosphorine drugs for treating immune disorders |
| 08/20/2008 | EP1957066A2 Acetylated amino acids as anti-platelet agents, nutritional and vitamin supplements |
| 08/20/2008 | EP1957054A2 Fast-acting oral peptide pharmaceutical products |
| 08/20/2008 | EP1956929A2 An edible composition |
| 08/20/2008 | EP1956906A2 Methods, compositions, and kits for the treatment of medical conditions |
| 08/20/2008 | EP1784203A4 Refolding transforming growth factor beta family proteins |
| 08/20/2008 | EP1765083A4 Use of il-17 in the treatment of fertility-related disorders |
| 08/20/2008 | EP1646366A4 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 08/20/2008 | EP1644402B1 Arginine/lysine-enriched peptides |
| 08/20/2008 | EP1633317A4 Synthetic chemokine receptor ligands and methods of use thereof |
| 08/20/2008 | EP1556488B1 Hf-chondroosteomodulin, production, and use for the treatment or diagnosis of bone diseases, cartilage diseases, obesity, inflammatory diseases, and skin diseases |
| 08/20/2008 | EP1546188B1 P53 binding t cell receptor molecules and uses thereof |
| 08/20/2008 | EP1530582A4 Diagnosis of kidney damage and protection against same |
| 08/20/2008 | EP1523336B1 Targeted agents for nerve regeneration |
| 08/20/2008 | EP1509618B1 Autoimmune conditions and nadph oxidase defects |
| 08/20/2008 | EP1502020B1 Stackable low depth tray |
| 08/20/2008 | EP1499284B1 Biologically active compounds for the modification of bodily odours |
| 08/20/2008 | EP1482976B1 A preparation and method for weight reduction |
| 08/20/2008 | EP1470153B1 Two gonadotropin releasing hormones and a method to isolate the same |
| 08/20/2008 | EP1461445B1 Glycoprotein remodeling using endoglycanases |
| 08/20/2008 | EP1446500B1 A method for regulating immune function in primates using the foxp3 protein |
| 08/20/2008 | EP1428530B1 Tetrapeptide derivative crystals |
| 08/20/2008 | EP1409654B1 Immunological control of beta-amyloid levels in vivo |
| 08/20/2008 | EP1387681B1 Use of castanospermine derivatives for the treatment of hepatitis c |
| 08/20/2008 | EP1374887B1 Novel agents for ameliorating motor disorder |
| 08/20/2008 | EP1368050B1 Virus derived antimicrobial peptides |
| 08/20/2008 | EP1368049B1 Inhibition of atf2 activity to treat cancer |
| 08/20/2008 | EP1357973B1 Gssp4 polynucleotides and polypeptides and uses thereof |
| 08/20/2008 | EP1345955B1 Lactam dipeptide and its use in inhibiting beta-amyloid peptide release |
| 08/20/2008 | EP1334123B1 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 08/20/2008 | EP1333850B1 Use of il-13 inhibitors for the treatment of tumors |
| 08/20/2008 | EP1232262B1 Recombinant gelatin in vaccines |
| 08/20/2008 | EP1227829B1 Novel chimeric analgesic peptides |
| 08/20/2008 | EP1210947B1 Ophthalmic ointment comprising vancomycin hydrochloride for treating infective eye diseases |
| 08/20/2008 | EP1198589B1 Tenascin-c nucleic acid ligands |
| 08/20/2008 | EP1176969B1 Substitution infusion fluid and citrate anticoagulation |
| 08/20/2008 | EP1087992B1 Antithrombotic compounds |
| 08/20/2008 | EP1044017B1 Supplement for dialysis patients |
| 08/20/2008 | EP0939829B1 Methods of modulating melanin synthesis |
| 08/20/2008 | EP0883404B1 Combination therapy for osteoporosis |
| 08/20/2008 | EP0826042B1 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
| 08/20/2008 | EP0794824B1 Method and device for separating fibrin monomer from blood plasma |
| 08/20/2008 | CN101248177A Therapeutic pro-apoptotic BH3-like molecules and methods for generating and/or selecting the same |
| 08/20/2008 | CN101248086A Supravalent compounds |
| 08/20/2008 | CN101248085A Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 08/20/2008 | CN101248083A NOGO receptor polypeptides and polypeptide fragments and uses thereof |
| 08/20/2008 | CN101247831A A method for modulating hla class II tumor cell surface expression with a cytokine mixture |
| 08/20/2008 | CN101247824A Application of treating inflammatory dermatosis by mixture of superoxide dismutase and catalase |
| 08/20/2008 | CN101247823A Use of bovine lactoferrin in the manufacture of a medicament for inhibiting the growth of bacteria |
| 08/20/2008 | CN101247822A EPO derivative-containing therapeutic agents for blood-related diseases |
| 08/20/2008 | CN101247821A Human interferon molecules and their uses |
| 08/20/2008 | CN101247820A Chaperonin 10-induced immunomodulation |
| 08/20/2008 | CN101247819A Methods for the treatment of anxiety and for identification of anxiolytic agents |
| 08/20/2008 | CN101247818A Use of MAS G-protein-coupled receptor agonists and antagonists as apoptotic activity modulators for prevention and treatment of diseases |
| 08/20/2008 | CN101247794A Formulation for a viptadil |
| 08/20/2008 | CN101247721A Pharmaceutical compositions comprising casein derived peptides and methods of use thereof |
| 08/20/2008 | CN101245344A Eriocheir sinensis lipotropism polyoses factor gene and encoding protein and application |
| 08/20/2008 | CN101245110A Recombined leukocyte inhibition factor and hirudo nipponica former peg-and-socket joint protein and pharmaceutical composition |
| 08/20/2008 | CN101245109A Polyglycol single-modificatory recombined human granular leukocyte colony stimulating factor mutant and preparation method thereof |
| 08/20/2008 | CN101245098A Antimicrobial antiphlogistic antagonism polypeptide simulating MD2 |
| 08/20/2008 | CN101245097A Inhibitors of serine proteases, particular hcv NS3-NS4 protease |
| 08/20/2008 | CN101244266A Composition for accelerating assimilation and improving digestive system imperfection |